Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1983-08

AUTHORS

Ben A. Oostra, Robert Harvey, Barry K. Ely, Alexander F. Markham, Alan E. Smith

ABSTRACT

The ability of polyoma virus to transform cells results primarily from the action of one of the virus-coded early proteins, called middle-T antigen1–3. Middle-T has an associated tyrosine-specific protein kinase activity that can be measured in vitro and results in the phosphorylation of middle-T itself4–7. Almost all mutants so far tested that lack the ability to transform cells, also lack associated kinase activity2,4. Attempts to map within middle-T the tyrosine residue(s) that are phosphorylated in vitro suggest that a likely site of phosphorylation is tyrosine 315 (refs8–10 and unpublished results). The amino acid sequence preceding Tyr 315 includes a tract of six contiguous glutamic acid residues and bears some homology with that preceding the tyrosine phosphorylated in vivo in pp60v–src, the transforming protein of Rous sarcoma virus11, and with a region in the polypeptide hormone, gastrin, preceding a tyrosine that is sulphated12. Furthermore, although surprisingly large tracts of middle-T may be removed without affecting its transforming activity2,13–16, mutants that lack the sequences corresponding to amino acids 311–318 inclusive are transformation defective. Because the likely site of phosphorylation, the homology with pp60v–src and gastrin and the sequence apparently required for transformation all overlap, it has generally been accepted that this region of middle-T may form part of an essential region, possibly an active site on the protein17. Here we have used techniques of site-directed and site-specific mutagenesis to probe the sequence requirements in more detail. Contrary to expectation, the results obtained strongly suggest that Tyr 315 and conservation of the surrounding amino acid sequence are not essential for transformation. More... »

PAGES

456-459

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/304456a0

DOI

http://dx.doi.org/10.1038/304456a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013713982

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6308461


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Polyomavirus Transforming", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Base Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Transformation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cloning, Molecular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Restriction Enzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasmids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyomavirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Viral Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oostra", 
        "givenName": "Ben A.", 
        "id": "sg:person.01237543367.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237543367.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harvey", 
        "givenName": "Robert", 
        "id": "sg:person.01175541603.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175541603.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ely", 
        "givenName": "Barry K.", 
        "id": "sg:person.01362275465.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362275465.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Markham", 
        "givenName": "Alexander F.", 
        "id": "sg:person.07405336557.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07405336557.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Alan E.", 
        "id": "sg:person.014034433464.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014034433464.71"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/292595a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020379194", 
          "https://doi.org/10.1038/292595a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/303435a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043637552", 
          "https://doi.org/10.1038/303435a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/292756a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035247002", 
          "https://doi.org/10.1038/292756a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1983-08", 
    "datePublishedReg": "1983-08-01", 
    "description": "The ability of polyoma virus to transform cells results primarily from the action of one of the virus-coded early proteins, called middle-T antigen1\u20133. Middle-T has an associated tyrosine-specific protein kinase activity that can be measured in vitro and results in the phosphorylation of middle-T itself4\u20137. Almost all mutants so far tested that lack the ability to transform cells, also lack associated kinase activity2,4. Attempts to map within middle-T the tyrosine residue(s) that are phosphorylated in vitro suggest that a likely site of phosphorylation is tyrosine 315 (refs8\u201310 and unpublished results). The amino acid sequence preceding Tyr 315 includes a tract of six contiguous glutamic acid residues and bears some homology with that preceding the tyrosine phosphorylated in vivo in pp60v\u2013src, the transforming protein of Rous sarcoma virus11, and with a region in the polypeptide hormone, gastrin, preceding a tyrosine that is sulphated12. Furthermore, although surprisingly large tracts of middle-T may be removed without affecting its transforming activity2,13\u201316, mutants that lack the sequences corresponding to amino acids 311\u2013318 inclusive are transformation defective. Because the likely site of phosphorylation, the homology with pp60v\u2013src and gastrin and the sequence apparently required for transformation all overlap, it has generally been accepted that this region of middle-T may form part of an essential region, possibly an active site on the protein17. Here we have used techniques of site-directed and site-specific mutagenesis to probe the sequence requirements in more detail. Contrary to expectation, the results obtained strongly suggest that Tyr 315 and conservation of the surrounding amino acid sequence are not essential for transformation.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/304456a0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5925", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "304"
      }
    ], 
    "keywords": [
      "amino acid sequence", 
      "Tyr-315", 
      "pp60v-src", 
      "acid sequence", 
      "tyrosine-specific protein kinase activity", 
      "polyoma virus middle T antigen", 
      "protein kinase activity", 
      "site-specific mutagenesis", 
      "middle T antigen", 
      "site-directed mutagenesis", 
      "glutamic acid residues", 
      "amino acids 311", 
      "contiguous glutamic acid residues", 
      "kinase activity", 
      "sequence requirements", 
      "essential region", 
      "acid residues", 
      "early proteins", 
      "phosphorylation", 
      "likely site", 
      "mutants", 
      "mutagenesis", 
      "homology", 
      "tyrosine", 
      "polyoma virus", 
      "large tracts", 
      "sequence", 
      "protein", 
      "active site", 
      "polypeptide hormones", 
      "cells", 
      "vitro", 
      "kinase", 
      "sites", 
      "conservation", 
      "residues", 
      "region", 
      "activity", 
      "vivo", 
      "ability", 
      "virus", 
      "more detail", 
      "hormone", 
      "tract", 
      "transformation", 
      "action", 
      "antigen", 
      "results", 
      "gastrin", 
      "lack", 
      "part", 
      "detail", 
      "requirements", 
      "attempt", 
      "expectations", 
      "technique"
    ], 
    "name": "Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis", 
    "pagination": "456-459", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013713982"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/304456a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6308461"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/304456a0", 
      "https://app.dimensions.ai/details/publication/pub.1013713982"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_171.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/304456a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/304456a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/304456a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/304456a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/304456a0'


 

This table displays all metadata directly associated to this object as RDF triples.

209 TRIPLES      21 PREDICATES      98 URIs      87 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/304456a0 schema:about N0d7cffa2c4b74156adb40f604d1c779b
2 N193224b1b2dc4e03bdc49185ad021f13
3 N3814fccd8e444689aee484efca0172b6
4 N408585715da04b1a809064b0ac066948
5 N445d9b004cf84bf8a91a043e4be7de24
6 N968ff05ba11745f49201750789d64f96
7 Nb08dda9c542b4aec87f0fa47afe17e16
8 Nbc4dd7ce7418492499fce50fc3356841
9 Nbf4d59351b344582a4e342e3232635b4
10 Nc733697dc9304397a4608017abe0ef31
11 Ncddc57dc426f4001bf2818115b741488
12 Ne05e2a83ff6545ecb10edb8cc7f4e652
13 Nf222e1297f714a23a379021e221f9793
14 anzsrc-for:06
15 anzsrc-for:0601
16 schema:author N36082481c56e4877ba778f950c92a065
17 schema:citation sg:pub.10.1038/292595a0
18 sg:pub.10.1038/292756a0
19 sg:pub.10.1038/303435a0
20 schema:datePublished 1983-08
21 schema:datePublishedReg 1983-08-01
22 schema:description The ability of polyoma virus to transform cells results primarily from the action of one of the virus-coded early proteins, called middle-T antigen1–3. Middle-T has an associated tyrosine-specific protein kinase activity that can be measured in vitro and results in the phosphorylation of middle-T itself4–7. Almost all mutants so far tested that lack the ability to transform cells, also lack associated kinase activity2,4. Attempts to map within middle-T the tyrosine residue(s) that are phosphorylated in vitro suggest that a likely site of phosphorylation is tyrosine 315 (refs8–10 and unpublished results). The amino acid sequence preceding Tyr 315 includes a tract of six contiguous glutamic acid residues and bears some homology with that preceding the tyrosine phosphorylated in vivo in pp60v–src, the transforming protein of Rous sarcoma virus11, and with a region in the polypeptide hormone, gastrin, preceding a tyrosine that is sulphated12. Furthermore, although surprisingly large tracts of middle-T may be removed without affecting its transforming activity2,13–16, mutants that lack the sequences corresponding to amino acids 311–318 inclusive are transformation defective. Because the likely site of phosphorylation, the homology with pp60v–src and gastrin and the sequence apparently required for transformation all overlap, it has generally been accepted that this region of middle-T may form part of an essential region, possibly an active site on the protein17. Here we have used techniques of site-directed and site-specific mutagenesis to probe the sequence requirements in more detail. Contrary to expectation, the results obtained strongly suggest that Tyr 315 and conservation of the surrounding amino acid sequence are not essential for transformation.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N43c9a773a69b45eab212b0ba18077fc4
26 Nc94ae2012a09490287a081160381cb7b
27 sg:journal.1018957
28 schema:keywords Tyr-315
29 ability
30 acid residues
31 acid sequence
32 action
33 active site
34 activity
35 amino acid sequence
36 amino acids 311
37 antigen
38 attempt
39 cells
40 conservation
41 contiguous glutamic acid residues
42 detail
43 early proteins
44 essential region
45 expectations
46 gastrin
47 glutamic acid residues
48 homology
49 hormone
50 kinase
51 kinase activity
52 lack
53 large tracts
54 likely site
55 middle T antigen
56 more detail
57 mutagenesis
58 mutants
59 part
60 phosphorylation
61 polyoma virus
62 polyoma virus middle T antigen
63 polypeptide hormones
64 pp60v-src
65 protein
66 protein kinase activity
67 region
68 requirements
69 residues
70 results
71 sequence
72 sequence requirements
73 site-directed mutagenesis
74 site-specific mutagenesis
75 sites
76 technique
77 tract
78 transformation
79 tyrosine
80 tyrosine-specific protein kinase activity
81 virus
82 vitro
83 vivo
84 schema:name Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis
85 schema:pagination 456-459
86 schema:productId N02d8f5d0870f4f3ea418ab1239c1fb02
87 Nc6718d5f071344a2bca0061b20a20d36
88 Nd7422bf558884b3997372cac62e084c5
89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013713982
90 https://doi.org/10.1038/304456a0
91 schema:sdDatePublished 2022-08-04T16:50
92 schema:sdLicense https://scigraph.springernature.com/explorer/license/
93 schema:sdPublisher N3932e46bfc2a43bc93e6f153a69a32e4
94 schema:url https://doi.org/10.1038/304456a0
95 sgo:license sg:explorer/license/
96 sgo:sdDataset articles
97 rdf:type schema:ScholarlyArticle
98 N02d8f5d0870f4f3ea418ab1239c1fb02 schema:name dimensions_id
99 schema:value pub.1013713982
100 rdf:type schema:PropertyValue
101 N0d7cffa2c4b74156adb40f604d1c779b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Genes, Viral
103 rdf:type schema:DefinedTerm
104 N193224b1b2dc4e03bdc49185ad021f13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Protein-Tyrosine Kinases
106 rdf:type schema:DefinedTerm
107 N36082481c56e4877ba778f950c92a065 rdf:first sg:person.01237543367.69
108 rdf:rest N929a15ac33a1428fb4bb429caa8f98fe
109 N3814fccd8e444689aee484efca0172b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Base Sequence
111 rdf:type schema:DefinedTerm
112 N3932e46bfc2a43bc93e6f153a69a32e4 schema:name Springer Nature - SN SciGraph project
113 rdf:type schema:Organization
114 N408585715da04b1a809064b0ac066948 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Polyomavirus
116 rdf:type schema:DefinedTerm
117 N43c9a773a69b45eab212b0ba18077fc4 schema:issueNumber 5925
118 rdf:type schema:PublicationIssue
119 N445d9b004cf84bf8a91a043e4be7de24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Protein Kinases
121 rdf:type schema:DefinedTerm
122 N8f9005eed21648e2adf52ee4453ac349 rdf:first sg:person.07405336557.74
123 rdf:rest Nec14507935a54d9ebf63ef6e2526f5c2
124 N929a15ac33a1428fb4bb429caa8f98fe rdf:first sg:person.01175541603.55
125 rdf:rest Nf5ac4d9f3e19422eb46def1b1d477cd8
126 N968ff05ba11745f49201750789d64f96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Cloning, Molecular
128 rdf:type schema:DefinedTerm
129 Nb08dda9c542b4aec87f0fa47afe17e16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Mutation
131 rdf:type schema:DefinedTerm
132 Nbc4dd7ce7418492499fce50fc3356841 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Cell Transformation, Neoplastic
134 rdf:type schema:DefinedTerm
135 Nbf4d59351b344582a4e342e3232635b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Antigens, Polyomavirus Transforming
137 rdf:type schema:DefinedTerm
138 Nc6718d5f071344a2bca0061b20a20d36 schema:name doi
139 schema:value 10.1038/304456a0
140 rdf:type schema:PropertyValue
141 Nc733697dc9304397a4608017abe0ef31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Amino Acid Sequence
143 rdf:type schema:DefinedTerm
144 Nc94ae2012a09490287a081160381cb7b schema:volumeNumber 304
145 rdf:type schema:PublicationVolume
146 Ncddc57dc426f4001bf2818115b741488 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name DNA Restriction Enzymes
148 rdf:type schema:DefinedTerm
149 Nd7422bf558884b3997372cac62e084c5 schema:name pubmed_id
150 schema:value 6308461
151 rdf:type schema:PropertyValue
152 Ne05e2a83ff6545ecb10edb8cc7f4e652 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Plasmids
154 rdf:type schema:DefinedTerm
155 Nec14507935a54d9ebf63ef6e2526f5c2 rdf:first sg:person.014034433464.71
156 rdf:rest rdf:nil
157 Nf222e1297f714a23a379021e221f9793 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Viral Proteins
159 rdf:type schema:DefinedTerm
160 Nf5ac4d9f3e19422eb46def1b1d477cd8 rdf:first sg:person.01362275465.69
161 rdf:rest N8f9005eed21648e2adf52ee4453ac349
162 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
163 schema:name Biological Sciences
164 rdf:type schema:DefinedTerm
165 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
166 schema:name Biochemistry and Cell Biology
167 rdf:type schema:DefinedTerm
168 sg:journal.1018957 schema:issn 0028-0836
169 1476-4687
170 schema:name Nature
171 schema:publisher Springer Nature
172 rdf:type schema:Periodical
173 sg:person.01175541603.55 schema:affiliation grid-institutes:grid.451388.3
174 schema:familyName Harvey
175 schema:givenName Robert
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175541603.55
177 rdf:type schema:Person
178 sg:person.01237543367.69 schema:affiliation grid-institutes:grid.451388.3
179 schema:familyName Oostra
180 schema:givenName Ben A.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237543367.69
182 rdf:type schema:Person
183 sg:person.01362275465.69 schema:affiliation grid-institutes:grid.451388.3
184 schema:familyName Ely
185 schema:givenName Barry K.
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362275465.69
187 rdf:type schema:Person
188 sg:person.014034433464.71 schema:affiliation grid-institutes:grid.451388.3
189 schema:familyName Smith
190 schema:givenName Alan E.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014034433464.71
192 rdf:type schema:Person
193 sg:person.07405336557.74 schema:affiliation grid-institutes:grid.451388.3
194 schema:familyName Markham
195 schema:givenName Alexander F.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07405336557.74
197 rdf:type schema:Person
198 sg:pub.10.1038/292595a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020379194
199 https://doi.org/10.1038/292595a0
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/292756a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035247002
202 https://doi.org/10.1038/292756a0
203 rdf:type schema:CreativeWork
204 sg:pub.10.1038/303435a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043637552
205 https://doi.org/10.1038/303435a0
206 rdf:type schema:CreativeWork
207 grid-institutes:grid.451388.3 schema:alternateName Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK
208 schema:name Biochemistry Division, National Institute for Medical Research, Mill Hill, NW7 1AA, London, UK
209 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...